Lilly and Novo Are Reportedly Near a Deal, Offering $149 GLP-1s in Return for Coverage in Medicare
Shares:
One of the most important needs in the biopharma industry is communicators who can make the case not only for innovation but also for the broader policy and business environment
I’m down in Miami this week for the Drug Channels Leadership Forum. If you’re here, say hi at the reception tonight. If you have a colleague that’s here, let me
It’s a late-arriving Curve today because I’m on the road talking to people in the flesh like it’s 2018 or something. They’ve been great meetings, with some interesting reader feedback,